Annual Retained Earnings
-$825.68 M
-$259.34 M-45.79%
March 31, 2024
Summary
- As of February 12, 2025, IMVT annual retained earnings is -$825.68 million, with the most recent change of -$259.34 million (-45.79%) on March 31, 2024.
- During the last 3 years, IMVT annual retained earnings has fallen by -$627.03 million (-315.63%).
- IMVT annual retained earnings is now -206420650.00% below its all-time high of -$400.00, reached on December 31, 2018.
Performance
IMVT Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$1.13 B
-$111.12 M-10.87%
December 31, 2024
Summary
- As of February 12, 2025, IMVT quarterly retained earnings is -$1.13 billion, with the most recent change of -$111.12 million (-10.87%) on December 31, 2024.
- Over the past year, IMVT quarterly retained earnings has dropped by -$382.71 million (-51.00%).
- IMVT quarterly retained earnings is now -369299.74% below its all-time high of $306.90 thousand, reached on September 30, 2019.
Performance
IMVT Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
IMVT Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -45.8% | -51.0% |
| 3 y3 years | -315.6% | -267.6% |
| 5 y5 years | -805.1% | -1503.2% |
IMVT Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -315.6% | at low | -267.6% | at low |
| 5 y | 5-year | <-9999.0% | at low | -1503.2% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low |
Immunovant Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | -$1.13 B(+10.9%) |
| Sep 2024 | - | -$1.02 B(+12.0%) |
| Jun 2024 | - | -$912.83 M(+10.6%) |
| Mar 2024 | -$825.68 M(+45.8%) | -$825.68 M(+10.0%) |
| Dec 2023 | - | -$750.36 M(+7.4%) |
| Sep 2023 | - | -$698.95 M(+9.2%) |
| Jun 2023 | - | -$640.28 M(+13.1%) |
| Mar 2023 | -$566.35 M(+59.4%) | -$566.35 M(+11.7%) |
| Dec 2022 | - | -$506.92 M(+14.3%) |
| Sep 2022 | - | -$443.69 M(+12.1%) |
| Jun 2022 | - | -$395.76 M(+11.4%) |
| Mar 2022 | -$355.39 M | -$355.39 M(+15.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | - | -$308.22 M(+15.5%) |
| Sep 2021 | - | -$266.83 M(+16.5%) |
| Jun 2021 | - | -$229.13 M(+15.3%) |
| Mar 2021 | -$198.66 M(+117.8%) | -$198.66 M(+16.5%) |
| Dec 2020 | - | -$170.50 M(+22.9%) |
| Sep 2020 | - | -$138.72 M(+17.6%) |
| Jun 2020 | - | -$117.93 M(+29.3%) |
| Mar 2020 | -$91.23 M(>+9900.0%) | -$91.23 M(+29.1%) |
| Dec 2019 | - | -$70.67 M(<-9900.0%) |
| Sep 2019 | - | $306.90 K(+68.7%) |
| Jun 2019 | - | $181.90 K(<-9900.0%) |
| Mar 2019 | - | -$900.00 |
| Dec 2018 | -$400.00 | - |
FAQ
- What is Immunovant annual retained earnings?
- What is the all time high annual retained earnings for Immunovant?
- What is Immunovant annual retained earnings year-on-year change?
- What is Immunovant quarterly retained earnings?
- What is the all time high quarterly retained earnings for Immunovant?
- What is Immunovant quarterly retained earnings year-on-year change?
What is Immunovant annual retained earnings?
The current annual retained earnings of IMVT is -$825.68 M
What is the all time high annual retained earnings for Immunovant?
Immunovant all-time high annual retained earnings is -$400.00
What is Immunovant annual retained earnings year-on-year change?
Over the past year, IMVT annual retained earnings has changed by -$259.34 M (-45.79%)
What is Immunovant quarterly retained earnings?
The current quarterly retained earnings of IMVT is -$1.13 B
What is the all time high quarterly retained earnings for Immunovant?
Immunovant all-time high quarterly retained earnings is $306.90 K
What is Immunovant quarterly retained earnings year-on-year change?
Over the past year, IMVT quarterly retained earnings has changed by -$382.71 M (-51.00%)